Case Study

Using Decentralized Trial Technology to Ensure Study Continuity and Data Quality During COVID-19 and Beyond

Using Decentralized Trial Technology to Ensure Study Continuity and Data Quality During COVID-19 and Beyond

Pages 22 Pages

Faster, smarter medical research. Schedule a demo Using Decentralized Trial Technology to Ensure Study Continuity and Data Quality During COVID-19 and Beyond Why patient-centric, remote research technologies such as eConsent, EDC, and ePRO are the key to success Decentralized and hybrid trials are garnering more attention in response to the pandemic. In this paper, learn steps to decentralize applicable trial elements, regulatory considerations for remote research, and key considerations for choosing a decentralized software vendor.Faster, smarter medical research. Schedule a demo castoredc.com | 2 Introduction 3 Decentralized and hybrid trials vs. traditional trials 4 Decentralized and hybrid trial elements aid research continuity during the pandemic 7 Biggest value drivers of decen

Join for free to read